药品收入构成比降低前后的药品应用对比分析

Comparative analysis on drugs application before and after composition proportion of income from drugs is reduced

2002年1-6月我院药品收入比2001年同期减少了2550万元(27.8％),按销售金额计算抗微生物感染药物、心血管系统药物、消化系统药物、激素类药物及影响免疫功能药物等合计减少了1861万元,占2002年药品收入减少金额的73.0％。应用金额超过50万元的大额应用药品品牌数量及总金额均有明显下降,分别从2001年的36种、3351万元降低到2002年的21种、1759万元,减少药品收入1592万元,占2002年药品收入减少金额的62.4％。控制药品收入构成比的重点是抗微生物感染药物及有关的辅助治疗药物,同时要控制单一品牌应用金额较大的药物。

From January to June of 2002, the income proportion from drugs in this hospital reduced by 25,500 thousand Yuan (27.8%) against the same period of 2001, according to the gross sales, the income from the drugs for antimicrobial infection, cardiovascular system, digestive system, hormone drugs and drugs to adjust immune function reduced by 18,610 thousand Yuan (73.0% of the reduced proportion from drugs in 2002). The number of brand drugs' application amount of over 500 thousand Yuan and the total amount reduced remarkably, respectively 36 brand drugs and 33,510 thousand Yuan applied in 2001, and they reduced to 21 brand drugs and 17,590 thousand Yuan in 2002 respectively (62.4% of the reduced proportion from drugs in 2002). The key to control the composition proportion of income from drugs is the drugs for antimicrobial infection and the relevant drugs for adjuvant treatment; meanwhile, the single brand drugs with larger application amount should also be controlled.